These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 12694568)
1. FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy. van Sorge NM; van der Pol WL; van de Winkel JG Tissue Antigens; 2003 Mar; 61(3):189-202. PubMed ID: 12694568 [TBL] [Abstract][Full Text] [Related]
2. IgG receptor polymorphisms: risk factors for disease. van der Pol W; van de Winkel JG Immunogenetics; 1998 Aug; 48(3):222-32. PubMed ID: 9683667 [TBL] [Abstract][Full Text] [Related]
3. FcgammaRIIa-131R allele and FcgammaRIIIa-176V/V genotype are risk factors for progression of IgA nephropathy. Tanaka Y; Suzuki Y; Tsuge T; Kanamaru Y; Horikoshi S; Monteiro RC; Tomino Y Nephrol Dial Transplant; 2005 Nov; 20(11):2439-45. PubMed ID: 16221721 [TBL] [Abstract][Full Text] [Related]
4. IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barré syndrome. van der Pol WL; van den Berg LH; Scheepers RH; van der Bom JG; van Doorn PA; van Koningsveld R; van den Broek MC; Wokke JH; van de Winkel JG Neurology; 2000 Apr; 54(8):1661-5. PubMed ID: 10762510 [TBL] [Abstract][Full Text] [Related]
5. Fc gamma RIIa, IIIa and IIIb polymorphisms in Turkish children susceptible to recurrent infectious diseases. Ozturk C; Aksu G; Berdeli A; Kutukculer N Clin Exp Med; 2006 Mar; 6(1):27-32. PubMed ID: 16550341 [TBL] [Abstract][Full Text] [Related]
6. Evidence for non-random distribution of Fcgamma receptor genotype combinations. van der Pol WL; Jansen MD; Sluiter WJ; van de Sluis B; Leppers-van de Straat FG; Kobayashi T; Westendorp RG; Huizinga TW; van de Winkel JG Immunogenetics; 2003 Jul; 55(4):240-6. PubMed ID: 12830330 [TBL] [Abstract][Full Text] [Related]
7. Association between Fcγ receptor IIA, IIIA and IIIB genetic polymorphisms and susceptibility to severe malaria anemia in children in western Kenya. Munde EO; Okeyo WA; Raballah E; Anyona SB; Were T; Ong'echa JM; Perkins DJ; Ouma C BMC Infect Dis; 2017 Apr; 17(1):289. PubMed ID: 28427365 [TBL] [Abstract][Full Text] [Related]
8. Fcγ receptor polymorphisms and clinical efficacy of rituximab in non-Hodgkin lymphoma and chronic lymphocytic leukemia. Zhuang Y; Xu W; Shen Y; Li J Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):347-52. PubMed ID: 21030347 [TBL] [Abstract][Full Text] [Related]
9. Genetic variation of human neutrophil Fcγ receptors and SIRPα in antibody-dependent cellular cytotoxicity towards cancer cells. Treffers LW; Zhao XW; van der Heijden J; Nagelkerke SQ; van Rees DJ; Gonzalez P; Geissler J; Verkuijlen P; van Houdt M; de Boer M; Kuijpers TW; van den Berg TK; Matlung HL Eur J Immunol; 2018 Feb; 48(2):344-354. PubMed ID: 28952147 [TBL] [Abstract][Full Text] [Related]
10. The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases. Karassa FB; Trikalinos TA; Ioannidis JP Biomed Pharmacother; 2004 Jun; 58(5):286-91. PubMed ID: 15194164 [TBL] [Abstract][Full Text] [Related]
11. No association of Fc gamma RIIa, Fc gamma RIIIa and Fc gamma RIIIb polymorphisms with MS. Breij EC; van der Pol WL; van Winsen L; Jansen MD; Dijkstra CD; van de Winkel JG; Uitdehaag BM J Neuroimmunol; 2003 Jul; 140(1-2):210-5. PubMed ID: 12864991 [TBL] [Abstract][Full Text] [Related]
12. FcγR polymorphisms and clinical outcome in colorectal cancer patients receiving passive or active antibody treatment. Wang B; Kokhaei P; Mellstedt H; Liljefors M Int J Oncol; 2010 Dec; 37(6):1599-606. PubMed ID: 21042730 [TBL] [Abstract][Full Text] [Related]
13. The IgG Fc receptor family. Gessner JE; Heiken H; Tamm A; Schmidt RE Ann Hematol; 1998 Jun; 76(6):231-48. PubMed ID: 9692811 [TBL] [Abstract][Full Text] [Related]
14. Genetic Variation in Low-To-Medium-Affinity Fcγ Receptors: Functional Consequences, Disease Associations, and Opportunities for Personalized Medicine. Nagelkerke SQ; Schmidt DE; de Haas M; Kuijpers TW Front Immunol; 2019; 10():2237. PubMed ID: 31632391 [TBL] [Abstract][Full Text] [Related]
15. Cell-specific, activation-dependent regulation of neutrophil CD32A ligand-binding function. Nagarajan S; Venkiteswaran K; Anderson M; Sayed U; Zhu C; Selvaraj P Blood; 2000 Feb; 95(3):1069-77. PubMed ID: 10648424 [TBL] [Abstract][Full Text] [Related]
16. Role of Fcgamma receptors in glomerulonephritis. Tarzi RM; Cook HT Nephron Exp Nephrol; 2003; 95(1):e7-12. PubMed ID: 14520009 [TBL] [Abstract][Full Text] [Related]
17. Impact of Human FcγR Gene Polymorphisms on IgG-Triggered Cytokine Release: Critical Importance of Cell Assay Format. Hussain K; Hargreaves CE; Rowley TF; Sopp JM; Latham KV; Bhatta P; Sherington J; Cutler RM; Humphreys DP; Glennie MJ; Strefford JC; Cragg MS Front Immunol; 2019; 10():390. PubMed ID: 30899264 [TBL] [Abstract][Full Text] [Related]
18. FcgammaRIIA and FcgammaRIIIB polymorphisms in myasthenia gravis. Raknes G; Skeie GO; Gilhus NE; Aadland S; Vedeler C J Neuroimmunol; 1998 Jan; 81(1-2):173-6. PubMed ID: 9521619 [TBL] [Abstract][Full Text] [Related]